PLYX

Polaryx TherapeuticsB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

View Chart

Peers tracked

U.S. public peers

Grade Position

Above peers

vs peer average

PLYX vs peer average

78/100

PLYX vs. peer average (B vs. D)

Grade spread

A 1 · B 1 · C 3 · D 1 · F 5

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

CUE is the first available peer comparator.

Loose clinical-stage biotech peer where valuation depends more on trial-timeline credibility and financing access than current revenue, making it useful mainly for event-risk framing.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerCUECue Biopharma

PLYX

Polaryx Therapeutics

CUE

Cue Biopharma

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Constructive

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs CUE

PLYX / CUE

Grade Position

Above peers

PLYX vs. peer average (B vs. D)

78/100

Momentum

PLYX

Value

PLYX

Sentiment

PLYX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs PLYX

CUE

40/100

PEPG

20/100

ENGN

80/100

Even

SEER

Seer Inc Class A Common

20/100

RFL

Rafael Holdings Inc Class B Common

20/100

CUE is the first peer returned for this comparison set.